Jie Tang

8.9k total citations · 1 hit paper
229 papers, 5.8k citations indexed

About

Jie Tang is a scholar working on Organic Chemistry, Molecular Biology and Surgery. According to data from OpenAlex, Jie Tang has authored 229 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Organic Chemistry, 52 papers in Molecular Biology and 37 papers in Surgery. Recurrent topics in Jie Tang's work include Catalytic Cross-Coupling Reactions (22 papers), Ovarian cancer diagnosis and treatment (18 papers) and Catalytic C–H Functionalization Methods (17 papers). Jie Tang is often cited by papers focused on Catalytic Cross-Coupling Reactions (22 papers), Ovarian cancer diagnosis and treatment (18 papers) and Catalytic C–H Functionalization Methods (17 papers). Jie Tang collaborates with scholars based in China, United States and France. Jie Tang's co-authors include Fan Yang, Mingyuan He, Gang Zou, Min Shi, Leping Liu, Huaping Zhu, Rongyu Zang, Wen‐Wei Qiu, Yang Wang and Fabien Miomandre and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Jie Tang

219 papers receiving 5.8k citations

Hit Papers

Celecoxib for the Prevention of Colorectal Adenomatous Po... 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Tang China 41 1.6k 1.5k 815 632 596 229 5.8k
Koji Kawai Japan 32 908 0.6× 1.5k 1.0× 478 0.6× 1.1k 1.7× 229 0.4× 222 4.4k
Yan Luo China 40 1.1k 0.7× 2.3k 1.5× 765 0.9× 529 0.8× 719 1.2× 201 6.2k
Flavio Rizzolio Italy 42 736 0.5× 2.9k 1.9× 1.0k 1.2× 339 0.5× 1.4k 2.4× 182 6.9k
Jiao Wang China 46 413 0.3× 3.4k 2.2× 1.1k 1.3× 249 0.4× 1.1k 1.9× 245 7.7k
Hiroshi Miki Japan 32 565 0.3× 1.5k 1.0× 816 1.0× 425 0.7× 207 0.3× 135 4.3k
Norihiro Tada Japan 41 2.7k 1.7× 1.6k 1.0× 234 0.3× 270 0.4× 118 0.2× 201 5.8k
Qing Yao China 43 197 0.1× 1.8k 1.2× 530 0.7× 633 1.0× 1.2k 2.0× 172 5.2k
Jidong Zhang China 37 439 0.3× 1.2k 0.8× 374 0.5× 334 0.5× 221 0.4× 193 4.8k
M. Zabel Poland 40 240 0.1× 2.9k 1.9× 1.8k 2.2× 641 1.0× 293 0.5× 427 6.7k
Thomas Mueller Germany 34 576 0.4× 1.0k 0.7× 650 0.8× 425 0.7× 636 1.1× 113 3.1k

Countries citing papers authored by Jie Tang

Since Specialization
Citations

This map shows the geographic impact of Jie Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Tang more than expected).

Fields of papers citing papers by Jie Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Tang. The network helps show where Jie Tang may publish in the future.

Co-authorship network of co-authors of Jie Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Tang. A scholar is included among the top collaborators of Jie Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Tang. Jie Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Jie, et al.. (2025). Dual targeting of FSP1 and xCT: Potential mechanism of anthocyanins in alleviating neuronal ferroptosis in vascular dementia. Phytomedicine. 142. 156608–156608. 1 indexed citations
2.
Ma, Yue, et al.. (2025). Efficient and reversible iodine capture by imidazolium cyclophanes synergized by cationic effects. Science China Chemistry. 68(10). 4922–4928. 1 indexed citations
3.
Zhu, Jianqing, Guangyi Jiang, Jie Tang, et al.. (2025). SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control Phase 2 Study. International Journal of Gynecological Cancer. 35(2). 101706–101706. 1 indexed citations
4.
Tang, Jie, et al.. (2024). Body composition and inflammation variables as the potential prognostic factors in epithelial ovarian cancer treated with Olaparib. Frontiers in Oncology. 14. 1359635–1359635. 3 indexed citations
5.
O’Byrne, Michael L., Priya Sharma, Jing Huang, et al.. (2024). Response of health-related quality of life following pediatric/congenital cardiac catheterization procedures. American Heart Journal. 281. 71–83. 1 indexed citations
7.
Chen, Yunhao, Chengli Du, Jie Tang, et al.. (2024). Super-enhancer-associated circPVT1 promotes malignancy of hepatocellular carcinoma via YBX1-mediated RRM2 activation. Cancer Letters. 611. 217395–217395. 2 indexed citations
9.
Tang, Jie, Xiaoxue Lu, Tao Zhang, et al.. (2023). Shiga toxin 2 A-subunit induces mitochondrial damage, mitophagy and apoptosis via the interaction of Tom20 in Caco-2 cells. Heliyon. 9(9). e20012–e20012. 3 indexed citations
10.
Zhang, Miaoyi, Jie Tang, Xue Yang, et al.. (2023). Evaluation of glymphatic-meningeal lymphatic system with intravenous gadolinium-based contrast-enhancement in cerebral small-vessel disease. European Radiology. 33(9). 6096–6106. 20 indexed citations
11.
Li, Jinglu, Yangyang Wang, Mingming Bian, et al.. (2023). The polarization of microglia and infiltrated macrophages in the injured mice spinal cords: a dynamic analysis. PeerJ. 11. e14929–e14929. 7 indexed citations
12.
Li, Jing, Peiying Ye, Yun You, et al.. (2023). A retrospective observational study on maternal and neonatal outcomes of COVID-19: Does the mild SARS-CoV-2 infection affect the outcome?. PeerJ. 11. e16651–e16651. 2 indexed citations
13.
Chen, Le, et al.. (2021). lncRNA LOC102724169 plus cisplatin exhibit the synergistic anti-tumor effect in ovarian cancer with chronic stress. Molecular Therapy — Nucleic Acids. 24. 294–309. 12 indexed citations
14.
Ni, Dan, et al.. (2021). FeTPPCl/FeCl3 Co-Catalyzed One-Pot Green Synthesis of α-Diaryl-β-alkynol Derivatives via Propargylic Carbocation Chemistry. The Journal of Organic Chemistry. 86(14). 9306–9316. 6 indexed citations
15.
Tang, Jie, et al.. (2020). Postoperative sufentanil intravenous patient-controlled analgesia within the first 24 hours: a retrospective study. Annals of Palliative Medicine. 9(6). 3932–3937. 9 indexed citations
16.
Ni, Dan, Shi‐Kun Jia, Suzhen Dong, et al.. (2020). C(sp2)–H Bond Multiple Functionalization in Air for Construction of Tetrahydrocarbazoles with Continuous Quaternary Carbons and Polycyclic Diversification. Organic Letters. 22(5). 1846–1851. 24 indexed citations
17.
Shi, Tingyan, Rong Jiang, Jinjin Yu, et al.. (2018). Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial. British Journal of Cancer. 119(1). 12–18. 7 indexed citations
18.
Wu, Yan, Lin Shen, Rui Wang, et al.. (2018). Increased ceruloplasmin expression caused by infiltrated leukocytes, activated microglia, and astrocytes in injured female rat spinal cords. Journal of Neuroscience Research. 96(7). 1265–1276. 10 indexed citations
19.
Gu, Y, et al.. (2018). Synthesis and Bioactivity Evaluation of Novel 1, 3, 5-Triazine-1H-pyrazole-triazol-ethiadiazole Derivatives. Chinese Journal of Organic Chemistry. 38(5). 1223–1223. 1 indexed citations
20.
Xue, Xiang, Jie Tang, Xi Cheng, et al.. (2012). Evaluation of Risk Factors for Venous Thromboembolism in Chinese Women With Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 23(1). 65–72. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026